A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

Fatty liver disease affects more than 1 in 3 adults and often has no symptoms. A new drug developed with Tulane researchers ...

Liver cancer is when a malignant tumor starts in or on the liver. Excess alcohol, hepatitis, and diabetes are risk factors. Learn more here about the symptoms, treatment, and how to prevent liver ...

Liver cancer is the fifth leading cause of cancer-related deaths, posing a significant health challenge in Hong Kong. The high mortality rate is due largely to late-stage detection, coupled with ...

This cancer is most commonly found in people living with chronic viral hepatitis, heavy alcohol use, or metabolic dysfunction-associated steatotic liver disease.

Current status of glucagon-like peptide-1 receptor agonists in metabolic dysfunction-associated steatotic liver disease: A clinical perspective Peer-Reviewed Publication Xia & He Publishing Inc.

Liver Cancer And Lifestyle Choices: It Starts With You As the saying goes "prevention is better than cure" -- both the challenge and solution begin with us and our lifestyle choices.

Detroit — The Barbara Ann Karmanos Cancer Institute on Wednesday announced that it is the first institute in the world to prescribe a new special kind of treatment for advanced liver cancer at ...

MD Anderson Cancer Center at Cooper became the first in New Jersey to destroy cancerous liver tumors with histotripsy.